Cited by 394Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 162 of the 166 references it cites were found in a registry or an index.

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Madras, Bertha K., Miller, Gregory M., Fischman, Alan J.·2005·Biological Psychiatry

DOI 10.1016/j.biopsych.2004.10.011

Open this paper in CoChat — free account

Abstract

The high incidence of attention-deficit/hyperactivity disorder (ADHD) and escalating use of ADHD medications present a compelling case for clarifying the pathophysiology of, and developing laboratory or radiologic tests for, ADHD. Currently, the majority of specific genes implicated in ADHD encode components of catecholamine signaling systems. Of these, the dopamine transporter (DAT) is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate); the DAT gene is associated with ADHD, and some studies have detected abnormal levels of the DAT in brain striatum of ADHD subjects. Medications for ADHD interfere with dopamine transport by brain-region- and drug-specific mechanisms, indirectly activating dopamine- and possibly norepinephrine-receptor subtypes that are implicated in enhancing attention and experiential salience. The most commonly used DAT-selective ADHD medications raise extracellular dopamine levels in DAT-rich brain regions. In brain regions expressing both the DAT and the norepinephrine transporter (NET), the relative contributions of dopamine and norepinephrine to ADHD pathophysiology and therapeutic response are obfuscated by the capacity of the NET to clear dopamine as well as norepinephrine. Thus, ADHD medications targeting DAT or NET might disperse dopamine widely and consign dopamine storage and release to regulation by noradrenergic, as well as dopaminergic neurons.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2004.10.011

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 995
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Self-citation
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651

Show all 166 references

Research works printed but not linked: 5

Barkley, 2001, vol. 9
Brown, 2001, Regulation of the vesicular monoamine transporter-2, J Pharmacol Exp Ther, 296, 762
DiMaio, 2003, Dopamine genes and attention-deficit hyperactivity disorder, J Psychiatry Neurosci, 28, 27
Galili-Weisstub, 2003, Attention deficit and hyperactivity disorder, Isr J Psychiatry Relat Sci, 40, 57
Goulet, 2000, Chronic methylphenidate treatment suppresses activity in more active juvenile monkeys and induces sleep disturbances, Soc Neurosci Abstracts, 26, 2177

Sorted by citations

Items 301–394 of 394

Discovery of potential attention deficit and hyperactivity disorder (ADHD) drug molecules from natural compounds: In silico studies with Tanimoto similarity
Ertik, O. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.109200 · Cited by 3
High dose methylphenidate in the treatment of freezing of gait in advanced Parkinson’s disease
Reyes, N. G. D., Bagnas, M. A. C., Antonio, A. K. D., & Jamora, R. D. G. (2017) · Basal Ganglia · doi:10.1016/j.baga.2017.12.001 · Cited by 3
Quantitative determination of amphetamine in plasma using negative ion chemical ionization GC ‐ MS of o‐(pentafluorobenzyl‐oxycarbonyl)‐2,3,4,5‐tetrafluorobenzoyl derivatives
Leis, H. J., & Windischhofer, W. (2012) · Journal of Separation Science · doi:10.1002/jssc.201200579 · Cited by 3
Effects of hippotherapy on brain function, BDNF level, and physical fitness in children with ADHD
Lee, N., Park, S., & Kim, J. (2015) · Physical Activity and Nutrition · doi:10.5717/jenb.2015.19.2.115 · Cited by 3
Rod‐Shaped NanoZnTPyP Paper‐Based Sensor for Visual Detection of Dopamine in Human Plasma
Yin, L., Du, Y., Ge, M., Zhang, X., Du, X., & Wu, X. (2025) · Journal of Analytical Methods in Chemistry · doi:10.1155/jamc/9981628 · Cited by 2
Applications of Clinical Dopamine Imaging
Lindsey, K. P., & Gatley, S. J. (2007) · PET Clinics · doi:10.1016/j.cpet.2007.09.005 · Cited by 2
Development of a Functionalized SiO2 Supported Ni Nanoparticles Based Non-Enzymatic Amperometric Dopamine Sensor
Yildirim, Y. E., & Güler, M. (2024) · Bitlis Eren Üniversitesi Fen Bilimleri Dergisi · doi:10.17798/bitlisfen.1490837 · Cited by 2
Auditory Event-Related Potentials in Two Rat Models of Attention-Deficit Hyperactivity Disorder: Evidence of Automatic Attention Deficits in Spontaneously Hypertensive Rats but Not in Latrophilin-3 Knockout Rats
Brewer, L. M., Patel, J. R., Andrasik, F., Sable, J. J., Williams, M. T., Vorhees, C. V., & Sable, H. J. K. (2025) · Genes · doi:10.3390/genes16060672 · Cited by 2
Developmental trajectories of “hot” executive functions across early childhood: contributions of maternal behavior and temperament
Graziano, P. A. (2009) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 2
Quantitative method for determination of amphetamine in plasma using negative ion chemical ionisation GC ‐ MS of o‐(pentafluorobenzyloxycarbonyl)‐benzoyl derivatives
Leis, H. J., & Windischhofer, W. (2012) · Journal of Separation Science · doi:10.1002/jssc.201200082 · Cited by 2
Effect of zinc supplementation in zinc-deficient children with attention-deficit hyperactivity disorder
Afifi, D., El-Bakry, A., Safty, A. E., Abdou, A., Amin, O., & Ayoub, D. R. (2019) · Egyptian Journal of Psychiatry · doi:10.4103/ejpsy.ejpsy_10_19 · Cited by 2
Neuropsychological and adaptive skills deficits in children with attention-deficit/hyperactivity disorder with and without comorbid fetal alcohol spectrum disorder
Boseck, J. J. (2012) · ProQuest Demo Repository · Cited by 2
Effects of children exposure to pyrethroid pesticides during infancy and toddlerhood on their ADHD symptoms at preschool age: A prospective study in Southwestern China
Luo, T., Xiao, X., Li, J., Chen, S., Gui, T., Song, X., & Li, Y. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116659 · Cited by 1
Characterizing functional connectivity gradients for the hippocampus–amygdala complex in healthy and psychiatric cohorts
Liu, X.-S., Vrijsen, J. N., Yan, L., Haak, K. V., Collard, R. M., van Eijndhoven, P., Beckmann, C. F., Fernández, G., Tendolkar, I., & Kohn, N. (2026) · Brain Structure and Function · doi:10.1007/s00429-026-03134-4 · Cited by 1
Light-induced secretion and transformation of neurotransmitter dopamine
Wei, S., Liu, C., Wu, Z., Si, J., Huo, X., Shen, C., Zhen, Y., Liu, D., & Chen, L. (2025) · Frontiers in Photonics · doi:10.3389/fphot.2025.1647467 · Cited by 1
The multiple mechanisms of NR4A2 in neurological disorders and advances in targeted therapy research
Duan, K., Yang, C., Gao, D., Li, M., Chen, M., Li, H., Zeng, W., Zhao, L.-J., & Zhu, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107229 · Cited by 3
Abnormal Behavior of Dopamine Transporter Knockout Rats During Early Ontogeny
Traktirov, D. S., Kulikova, E., Burdinskaya, V. O., Nazarov, I., Pestereva, N. S., Gainetdinov, R. R., & Karpenko, M. N. (2026) · Developmental Neurobiology · doi:10.1002/dneu.70023 · Cited by 1
Regulation of the genes involved in neurotransmission in Attention Deficit/Hyperactivity Disorder
Cuch, B., Polaczek, A., Idziak, M., Kotuła, L., Maciejewski, R., Madej, B., & Kocki, J. (2015) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2015-0056 · Cited by 1
Drug discovery
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00011-8 · Cited by 1
DAT1 and DRD4 genes involved in key dimensions of adult ADHD R. HaslerA. SalzmannT. Bolzan • J. ZimmermannP. BaudP. Giannakopoulos •
Perroud, N. A., & Italia, S.-V. (2015) · Cited by 1
Clinically relevant doses of methylphenidate elicit behavioral sensitization and impair cognition on drug withdrawal in normal adult rats
SumeraKanwal, Haleem, D. J., NaziaFeroz, Ammar, B., & Imtiaz, F. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.17.1.0290 · Cited by 1
A Meta-Analysis of the Efficacy of Immediate Release Methylphenidate to Reduce Hyperactivity in Children with Autistic Spectrum Disorder
(2017) · doi:10.29199/jpct.101014
Response Inhibition
Mochizuki, K., & Funahashi, S. (2016) · Innovations in cognitive neuroscience · doi:10.1007/978-1-4614-3846-5_7 · Cited by 1
Very early-onset of RBD with ADHD: a case report study
Takagi, S., Yamashiro, Y., Sugihara, G., Takahashi, H., & Matsuura, M. (2019) · Neurocase · doi:10.1080/13554794.2019.1697823 · Cited by 1
ERPS AS AN INDEX OF IMPAIRED WORKING MEMORY IN AN ISCHEMIC BRAIN STROKE APHASIC PATIENT AWAKENED FROM A LONG-TERM COMA FOLLOWING AN AMPHETAMINE OVERDOSE
Wilczek‐Rużyczka, E., Grzywniak, C., Korab, M., & Cielebąk, K. (2021) · Acta Neuropsychologica · doi:10.5604/01.3001.0014.8032 · Cited by 1
Grundlagen der Neuro-/Psychopharmakologie
Drepper, C., & Gerlach, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_1 · Cited by 1
Attention-Deficit Hyperactivity Disorder
Lipkin, P. H., & Mostofsky, S. H. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50059-1 · Cited by 1
The Effects of Assisted Cycle Therapy on Executive and Motor Functioning in Young Adult Females with Attention-Deficit Hyperactivity Disorder
Birchfield, N. (2014) · Cited by 1
Working Memory, Catecholamines and Psychosis: Illustrative Case
Lévy, F. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601050499 · Cited by 1
The impact of the SEMOSTI programme on the gross motor proficiency of four-to-six-year-old children
Salzwedel, E. (2012) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Impulsivity and Reward Sensitivity: Attentional and Emotional Factors Underlying Stimulus-Reward Learning
Petropoulos, A. (2010) · QSpace (Queen's University Library) · Cited by 1
Attention Deficit Hyperactivity Disorder (ADHD): Methylphenidate (Ritalin) and Dopamine
Vaidya, C., & Lee, P. S. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01143-8 · Cited by 3
Dissociable effects of ADHD and Methylphenidate treatment on the capture and the inhibition of impulsive actionsPreprint
Grandjean, A., Suárez, I., Fonséca, D. D., & Casini, L. A. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/s8nqt · Cited by 1
Grundlagen der Neuro-Psychopharmakologie
Gerlach, M. (2004) · Springer eBooks · doi:10.1007/978-3-7091-3791-8_1
Receptores de dopamina y heterómeros de receptores de dopamina en la modulación de la neurotransmisión
González‐Torres, S. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Atomoksetin Tedavisine Bağlı Ayrılma Anksiyetesi: Bir Olgu Sunumu
Çelik, G. G., Tahiroğlu, A. Y., & Avcı, A. (2013) · DergiPark (Istanbul University) · doi:10.17826/cutf.62223
Studies on neurodevelopmental issues in children
FERON, F. J. M. (2007) · doi:10.26481/dis.20070209ff
Genetic and Environmental Factors in Attention‐Deficit Hyperactivity Disorder
Baker, A. A., Taylor, M., & Richardson, J. R. (2010) · Wiley eBooks · doi:10.1002/9780470917060.ch14
Neurofeedback bei Kindern mit einer Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung - Ergebnisse auf Verhaltens- und neurophysiologischer Ebene
Gevensleben, H. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1440
Trace amine-associated receptor 1 : a novel target of methamphetamine
Reese, E. A. (2008) · doi:10.6083/m4zk5dnr
Therapy for ADHD Directed Towards Addressing the Dual Imbalances in Mental Effort and Reward as Illustrated in the Mental Effort-Reward Imbalances Model (MERIM)
Poulton, A. S. (2015) · InTech eBooks · doi:10.5772/60814 · Cited by 1
Attentional control and socio-emotional regulation during chilhood
Checa, P. (2011) · Institutional Repository of the University of Granada (University of Granada)
Moderator Effects of Working Memory on Symptom Stability in Attention-Deficit/Hyperactivity Disorder by Dopamine D1 and D2 Receptor Polymorphisms During Development
Trampush, J. W. (2010) · CUNY Academic Works (City University of New York)
EPINEPHRINE ADMINISTRATION AT BIRTH PREVENTS LONG-TERM CHANGES IN DOPAMINERGIC FUNCTION CAUSED BY CESAREAN SECTION BIRTH IN THE RAT
Boksa, P., & Zhang, Y. (2008) · Schizophrenia Research · doi:10.1016/s0920-9964(08)70178-6
PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES
Williams, Y. S. (2011) · UKnowledge (University of Kentucky)
Prescription Stimulants—Retaining the Benefits While Mitigating the Risk of Abuse
Volkow, N. D. (2006) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2006.11.3.1
Growth Monitoring on Psychotropic Medication
Poulton, A. S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_104
NEURAL BASIS OF AGING AND IMPLICIT ASSOCIATIVE LEARNING
Simon, J. R. (2011) · DigitalGeorgetown (Georgetown University Library)
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010
Polimorfismos nos genes DAT1 DRD4 e transtorno de déficits de atenção e hiperatividade (TDAH) em adultos
Marques, F. Z. (2006) · Americanae (AECID Library)
A Developmental Perspective on Attention-Defity Disorder (ADHD)
Campbell, S. B. G., Halperin, J. M., & Sonuga-Barke, E. J. S. (2014)
Adderall and Ritalin: The New Caffeine?
Haponenko, H. (2016) · The Meducator · doi:10.15173/m.v1i29.1179
The Impact of Methylphenidate on Circadian Rhythms and Clock Gene Expression
Coogan, A. N., Thome, J., & Baird, A. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00066-4
The role of the dopaminergic system in the regulation of physical activity in mice
Knab, A. M., & NC DOCKS at The University of North Carolina at Charlotte (2009) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Mechanisms of Autoreceptor-Mediated Inhibition in Central Monoamine Neurons
Courtney, N. A. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Intra-individual variability in adult ADHD: an exploration of the viability of distinct purely inattentive condition
Proto, D. A. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.654
Efeitos da sibutramina e do metilfenidato em modelo animal do Transtorno do Déficit de Atenção e Hiperatividade (TDAH) induzido em camundongos por etanol no período pós-natal
Bertaglia, E. B. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2017.tde-22062017-121424
ADHD symptoms in a young patient with central diabetes insipidus
Dupong, I., Guilmin‐Crépon, S., & Peyre, H. (2018) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-018-0264-y
Pharmacology
Ciruela, F., Franco, R., & Burgueño, J. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch18
Parent Reported Executive Functioning Does Not Predict Memory Dysfunction in Pediatric Epilepsy and Attention-Deficit/Hyperactivity Disorder
Norheim, N. J. (2018)
Dissociable effects of ADHD and Methylphenidate treatment on the capture and the inhibition of impulsive actionsPreprint
Grandjean, A., Suárez, I., Miquée, A., Fonséca, D. D., & Casini, L. A. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/5kzad
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents: An Investigative Study of Dopamine and Norepinephrine Systems
Knight, K. (2012) · UA Campus Repository (The University of Arizona)
Current awareness in human psychopharmacology
(2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.727
Mind-Body Medicine in Children and Adolescents
McClafferty, H. H. (2017) · MDPI eBooks · doi:10.3390/books978-3-03842-529-8
ADHS
Schmid, J., Loßnitzer, C., & Gawrilow, C. (2020) · Springer eBooks · doi:10.1007/978-3-662-45995-9_32-1 · Cited by 1
Author Index to Volume 57
(2005) · Biological Psychiatry · doi:10.1016/s0006-3223(05)00639-6
Introduction
Adler, L. A., & Newcorn, J. H. (2007) · CNS Spectrums · doi:10.1017/s1092852900003771
The FAST "Seizure-prone" rat strains; as a possible animal model of attention-deficit hyperactivity disorder (ADHD)
Waitman, J. (2007) · doi:10.22215/etd/2007-07507
Drug discovery: Standing on the shoulders of giants
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8
Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder
Karabulut, M., & Yıldırım, K. (2023) · Psychiatry Investigation · doi:10.30773/pi.2023.0162
Grundlagen der Neuro-/Psychopharmakologie
Gerlach, M., & Drepper, C. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_1
Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden
Walitza, S., Smigielski, L., & Gerlach, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_8 · Cited by 2
Sniffing can be initiated by dopamine’s actions on ventral striatum neuronsPreprint
Johnson, N. L., Cotelo-Larrea, A., Stetzik, L. A., Akkaya, U. M., Zhang, Z., Gadziola, M. A., Varga, A. G., Ma, M., & Wesson, D. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.19.581052
La gestion pharmacologique du traitement du TDAH
Parigny, L., Bioulac, S., & Carton, L. (2024) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2024.08.026
Methylphenidate—effects on orthodontic tooth movement, orthodontically induced and nonorthodontic root resorption?
Akce, B., Gök, G. D., Delipınar, S. D., & Kaleler, İ. (2025) · Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie · doi:10.1007/s00056-024-00567-6
Does Dexamphetamine Cause Addiction? A Narrative Review
Khalifa, H., Hibbert, E., Gauci, N., & Poulton, A. S. (2025) · Psychoactives · doi:10.3390/psychoactives4010003
The identification of new directions for the research of ADHD
Burkhardt, A. (2023) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/3nav-mt8w
Dopaminergic neuropathology in calves naturally infected with Neospora caninum
Anteplıoğlu, T., Türkmen, M. B., Öcal, N., Eser, E., İmrak, G., & Kul, O. (2025) · Veterinary Parasitology · doi:10.1016/j.vetpar.2025.110548
Potential treatments for attention-deficit/hyperactivity disorder: a focus on Phase III trials
Ferahkaya, H., & Bilgiç, A. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2566257 · Cited by 2
Remarkable therapeutic effects of methylphenidate in periodic limb movement disorder comorbid with excessive daytime sleepiness: a case report
Ren, J., Zhang, X., Zhou, J., & Liu, L. L. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1659120
Attention-deficit hyperactivity disorder associated gene variants and their impact on neuroanatomy
Alnefaie, Z. M., Almutairi, A. K., Alharbi, N. M., Almohammadi, F. M., Almetairi, A. K., Hakeem, A. H., Aljohani, B. F., & Raffah, O. M. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20253756
Animal models of attention-deficit/hyperactivity disorder: Diversity and validity
Nehme, S. B. S., Sánchez‐Sarasúa, S., Medrano, M., Bouchatta, O., Bitar, T., Alameddine, A., Galineau, L., Brunault, P., Kerekes, N., Sánchez‐Pérez, A. M., et al. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100108
N-Ethylmaleimide-Sensitive Factor Deletion in Dopamine D2 Receptor Cells and Associated Neuronal and Behavioural Changes in MicePreprint
Xie, M.-J., Murata, K., Kuniishi, H., Fukazawa, Y., Usui, N., & Matsuzaki, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.694809
Medication and Developmental Stage Shape the Brain-Age Gap in ADHDPreprint
Zhang, X., Yu, Y., Liu, X., Fang, Y., Wang, J., Frangou, S., Zang, Y., Ge, R., & Zhang, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.19.700322
Aniracetam restores the excitation-inhibition balance of neurotransmitters in the prefrontal cortex of mice with ADHD
Cui, J., Sun, X.-L., Shi, S., Bai, H., Zhang, W., & Bai, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-38725-y
Implication de la neurotrasmission glutamatergique dans des modèles pharmacologiques et génétiques relatifs aux maladies psychiatriques
Moutsimilli, L. (2008) · theses.fr (ABES) · doi:10.70675/d064f94fz2163z425az80bezffceb54179c3
Le contrôle de l'interférence chez les adolescents avec un trouble de l'attention avec ou sans hyperactivité (TDAH)
Grandjean, A. (2020) · theses.fr (ABES) · doi:10.70675/09142f43z5b6fz462bz83c7za94811509c36
Cortical mechanisms of comorbidity between pain sensitization and attention-deficit/hyperactivity disorder (ADHD) in a mouse model
Nehme, S. B. S. (2024) · theses.fr (ABES) · doi:10.70675/7ad70482z0961z4eebzbc86z84355cab1f1d
Reassessing ADHD Management: Integrating Gut Microbiome Insights and Herbal Nutritional Strategies
Elkalla, W. S., Salah, A. N., Mahmoud, N. A., AbdelRazek, M. M. M., Kotb, S. S., Elshami, N. H., AlFarsi, K., Waseem, A. M., Bogari, H. A., Malatani, R. T., et al. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00712-0
Detrimental effects of atomoxetine on visual signal detection in rats: comparison with ADHD psychomotor stimulant drugs
Versprille, L. J. F. W., Yano, K., Petersen, A., Dalley, J. W., & Robbins, T. W. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07131-7
Comparative Proteomic Analysis of the Striatum in Heterozygous and Null DAT Knockout Rats
Mittenberg, A. G., Belskaya, A. D., Shabelnikov, S., Fesenko, Z. S., Sylko, P. A., Gainetdinov, R. R., Volnova, A. B., & Vaganova, A. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177758
Deletion of N-ethylmaleimide-sensitive factor in dopamine D2 receptor-expressing cells impairs striatal development and dopaminergic function and induces ADHD-like behaviors in mice
Xie, M.-J., Murata, K., Kuniishi, H., Fukazawa, Y., Usui, N., & Matsuzaki, H. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02526-8
Effects of opioids and stimulants on the respiratory system
Lildharrie, C., Veenker, F. N., Miller, K. B., Yonga, M.-V., Abey, S., Wang, G.-J., Kim, S. W., Demiral, Ş., & Volkow, N. D. (2026) · European Respiratory Review · doi:10.1183/16000617.0092-2026
BindingDB Entry 50043450: The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.
BindingDB (2014) · UC San Diego · doi:10.7270/q2805413

Authors: Madras, B. K., Miller, G. M., & Fischman, A. J.
Affiliations: Harvard University (US)
Massachusetts General Hospital (US)
Corresponding author: Madras, Bertha K.
ORCID: Madras, Bertha K.
Miller, Gregory M.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2005-06
Volume: 57
Issue: 11
Pages: 1397-1409
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2004.10.011
OpenAlex: W2011083427
Cited by: 393
References: 166
Citations by year: 2026: 10 · 2025: 20 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 11 · 2016: 14 · 2015: 15 · 2014: 23 · 2013: 16 · 2012: 27
FWCI: 4.54
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA 06303, R01DA011558, K05DA015305, DA15305, DA 11558)
National Center for Research Resources (RR00 168)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: dopamine transporter, attention deficit hyperactivity disorder, ADHD pathophysiology, catecholamine signaling, norepinephrine transporter, amphetamine, methylphenidate, striatum, dopamine, norepinephrine, ADHD medication, genetic susceptibility
MeSH terms: Adaptation, Physiological, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Diagnostic Imaging, Humans, Membrane Glycoproteins, Mutation, Nerve Tissue Proteins, Genetic Variation, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Vesicular Biogenic Amine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks